RxDoctor Payments Data

Harry Strothers, MD

Geriatric Medicine · Macon, GANPI 1861492720

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,406 of the $10,415 with a category attached, or 71.1%. Novo Nordisk accounts for 92.9% of it on its own, with 16 other manufacturers making up the rest. 2024 is the largest year on record at $9,939, more than ten times the $114 reported in 2019. Among geriatric medicine clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,415in general payments, 2019–2025

Across 32 payments — averaging $325.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$10K
  • Eko Health, Inc.$200
  • Sanofi Pasteur Inc.$104
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$76
  • Abbott$68
  • Pfizer$57
  • plus $234 from 11 others

What the payments were for

  • Consulting fees$7,40671%
  • Speaking & faculty fees$2002%
  • Travel & lodging$1,74417%
  • Food & beverage$1,06410%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,415 in reported general payments places this provider in the 90th percentile of 75 geriatric medicine providers in Georgia.

See all geriatric medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$16,729
Medicare patients
57
Services billed
213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin54$73,589
TrulicityDulaglutide28$64,076
EliquisApixaban47$45,965
OzempicSemaglutide29$40,732
MounjaroTirzepatide15$19,212
JanumetSitagliptin Phos/Metformin Hcl12$18,164
FarxigaDapagliflozin Propanediol13$16,343
Lantus SolostarInsulin Glargine,hum.Rec.Anlog37$6,118
Albuterol Sulfate HfaAlbuterol Sulfate83$3,101
SymbicortBudesonide/Formoterol Fumarate11$3,009
Atorvastatin Calcium283$2,286
Pregabalin76$2,088
Gabapentin104$1,722
Estradiol12$1,679
Wixela InhubFluticasone Propion/Salmeterol12$1,443

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$17$83,28843 claims
PfizerEliquis$57$45,96547 claims
Novo NordiskOzempic$9,675$40,73229 claims
MerckJanumet$17$18,16412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 75 geriatric medicine providers in Georgia.

Other geriatric medicine in Macon

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →